Primary biliary cholangitis

A Lleo, GQ Wang, ME Gershwin, GM Hirschfield - The Lancet, 2020 - thelancet.com
Primary biliary cholangitis is an autoimmune liver disease that predominantly affects women.
It is characterised by a chronic and destructive, small bile duct, granulomatous lymphocytic …

Primary biliary cholangitis: Epidemiology, prognosis, and treatment

J Trivella, BV John, C Levy - Hepatology communications, 2023 - journals.lww.com
Primary biliary cholangitis (PBC) is a chronic cholestatic autoimmune liver disease
characterized by a destructive, small duct, and lymphocytic cholangitis, and marked by the …

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update

CPG Panel, A Berzigotti, E Tsochatzis, J Boursier… - Journal of …, 2021 - Elsevier
Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …

APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis

H You, X Ma, C Efe, G Wang, SH Jeong, K Abe… - Hepatology …, 2022 - Springer
Hong You1· Xiong Ma2· Cumali Efe3· Guiqiang Wang4· Sook‑Hyang Jeong5· Kazumichi
Abe6· Weijia Duan1· Sha Chen1· Yuanyuan Kong7· Dong Zhang8· Lai Wei9· Fu‑Sheng …

Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta‐analysis

T Lv, S Chen, M Li, D Zhang, Y Kong… - … of gastroenterology and …, 2021 - Wiley Online Library
Abstract Background and Aim We aimed to estimate the worldwide incidence and
prevalence, with focus on the geographical differences and temporal trends. Methods …

[HTML][HTML] Clinical updates in primary biliary cholangitis: trends, epidemiology, diagnostics, and new therapeutic approaches

A Galoosian, C Hanlon, J Zhang, EW Holt… - Journal of clinical and …, 2020 - ncbi.nlm.nih.gov
Primary biliary cholangitis, formerly known as primary biliary cirrhosis, is a chronic,
autoimmune, and cholestatic disease ameliorating the biliary epithelial system causing …

Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome

C Efe, M Torgutalp, I Henriksson… - Journal of …, 2021 - Wiley Online Library
Abstract Background and Aim The prevalence and clinical significance of extrahepatic
autoimmune diseases (EHAIDs) have not been evaluated in a large cohort of primary biliary …

Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis

R Vuppalanchi, SH Caldwell, N Pyrsopoulos… - Journal of …, 2022 - Elsevier
Background & Aim Saroglitazar is a novel peroxisome proliferator-activated receptor (PPAR)
agonist with dual agonistic properties (α/γ). Due to a strong mechanistic rationale, we aimed …

[HTML][HTML] Application of the latest advances in evidence-based medicine in primary biliary cholangitis

KV Kowdley, CL Bowlus, C Levy, MJ Mayo… - Official journal of the …, 2023 - journals.lww.com
Primary biliary cholangitis (PBC) is a chronic, cholestatic, autoimmune liver disease that can
progress to end-stage liver disease and its complications. A previous expert review panel …

原发性胆汁性胆管炎的诊断和治疗指南(2021).

尤红, 贾继东 - Journal of Clinical Hepatology/Linchuang …, 2022 - search.ebscohost.com
2015 年中华医学会肝病学分会和中华医学会消化病学分会制订了我国第一个原发性胆汁性胆管
炎(primary biliary cholangitis, PBC) 的专家共识. 近年来国内外有关研究为PBC …